Levent Kabasakal - Search Results

Year	Number of Results
2002	2
2003	4
2004	2
2005	8
2006	3
2007	1
2008	1
2009	1
2010	6
2011	4
2012	3
2013	9
2014	5
2015	6
2016	4
2017	6
2018	6
2019	5
2020	11
2021	6
2022	3
2023	7
2024	3

1

Joint EANM/SNMMI procedure guideline for the use of ¹⁷⁷Lu-labeled PSMA-targeted radioligand-therapy (¹⁷⁷Lu-PSMA-RLT).

Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Kratochwil C, et al. Among authors: kabasakal l. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845. doi: 10.1007/s00259-023-06255-8. Epub 2023 May 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37246997 Free PMC article.

2

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kabasakal L, Kaltsas G, Lewington V, Minozzi S, Cinquini M, Öberg K, Oyen WJG, O'Toole D, Pavel M, Ruszniewski P, Scarpa A, Strosberg J, Sundin A, Taïeb D, Virgolini I, Wild D, Herrmann K, Yao J. Ambrosini V, et al. Among authors: kabasakal l. Eur J Cancer. 2021 Mar;146:56-73. doi: 10.1016/j.ejca.2021.01.008. Epub 2021 Feb 12. Eur J Cancer. 2021. PMID: 33588146 Free PMC article. Review.

3

Clinical Experience with [²²⁵Ac]Ac-PSMA Treatment in Patients with [¹⁷⁷Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer.

Alan-Selcuk N, Beydagi G, Demirci E, Ocak M, Celik S, Oven BB, Toklu T, Karaaslan I, Akcay K, Sonmez O, Kabasakal L. Alan-Selcuk N, et al. Among authors: kabasakal l. J Nucl Med. 2023 Oct;64(10):1574-1580. doi: 10.2967/jnumed.123.265546. Epub 2023 Aug 24. J Nucl Med. 2023. PMID: 37620050

4

Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance.

Kabasakal L, Turkay R, Onal B. Kabasakal L, et al. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1464-1466. doi: 10.1007/s00259-024-06642-9. Eur J Nucl Med Mol Imaging. 2024. PMID: 38342786 No abstract available.

5

Prediction of clinically significant prostate cancer by [⁶⁸ Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.

Akcay K, Kibar A, Sahin OE, Demirbilek M, Beydagi G, Asa S, Aghazada F, Toklu T, Selcuk NA, Onal B, Kabasakal L. Akcay K, et al. Among authors: kabasakal l. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1467-1475. doi: 10.1007/s00259-023-06556-y. Epub 2023 Dec 19. Eur J Nucl Med Mol Imaging. 2024. PMID: 38112777

6

Combination therapy with chitosan/siRNA nanoplexes targeting PDGF-D and PDGFR-β reveals anticancer effect in breast cancer.

Şalva E, Özbaş S, Alan S, Özkan N, Ekentok-Atıcı C, Kabasakal L, Akbuğa J. Şalva E, et al. Among authors: kabasakal l. J Gene Med. 2023 Feb;25(2):e3465. doi: 10.1002/jgm.3465. Epub 2022 Dec 11. J Gene Med. 2023. PMID: 36413571

7

Ischemic colitis of the colon in streptozotocin-induced diabetic rats.

Ozel Y, Elcioglu HK, Cevikelli ZA, Kudas I, Ahmad S, Uzun H, Topal C, Aktas S, Kabasakal L. Ozel Y, et al. Among authors: kabasakal l. Mol Cell Biochem. 2018 Feb;439(1-2):87-93. doi: 10.1007/s11010-017-3138-2. Epub 2017 Aug 5. Mol Cell Biochem. 2018. PMID: 28780750

8

A novel treatment strategy for preterm birth: Intra-vaginal progesterone-loaded fibrous patches.

Cam ME, Hazar-Yavuz AN, Cesur S, Ozkan O, Alenezi H, Turkoglu Sasmazel H, Sayip Eroglu M, Brako F, Ahmed J, Kabasakal L, Ren G, Gunduz O, Edirisinghe M. Cam ME, et al. Among authors: kabasakal l. Int J Pharm. 2020 Oct 15;588:119782. doi: 10.1016/j.ijpharm.2020.119782. Epub 2020 Aug 19. Int J Pharm. 2020. PMID: 32822780

9

Almost Complete Response with a Single Administration ²²⁵Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary.

Alan Selçuk N, Demirci E, Ocak M, Toklu T, Ergen S, Kabasakal L. Alan Selçuk N, et al. Among authors: kabasakal l. Mol Imaging Radionucl Ther. 2022 Jun 27;31(2):139-141. doi: 10.4274/mirt.galenos.2022.64497. Mol Imaging Radionucl Ther. 2022. PMID: 35771003 Free PMC article.

10

Post-therapy imaging of ²²⁵Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor.

Ocak M, Toklu T, Demirci E, Selçuk N, Kabasakal L. Ocak M, et al. Among authors: kabasakal l. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2711-2712. doi: 10.1007/s00259-020-04725-x. Epub 2020 Mar 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 32123970 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year